Syncona Portfolio Ltd
- SEC CIK
- 0001725042
- Latest filing
- Aug 6, 2026
Holdings in Q2 2022
Holdings as of Jun 30, 2022, filed Aug 10, 2022. Long positions only; changes compare share counts with Q1 2022.
- Positions
- 4
- 0 vs. Q1 2022
- Portfolio value
- $70.4M
- −$34.3M (−32.8%) vs. Q1 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 11,086,909 | $27.9M | 39.7% | 00.0% | Unchanged | – |
| AUTLAutolus Therapeutics plc | SPON ADS | 7,346,829 | $20.8M | 29.5% | 00.0% | Unchanged | History |
| Freeline Therapeutics Hldgs35655L107 | SPONSORED ADS | 21,997,620 | $19.3M | 27.4% | 00.0% | Unchanged | – |
| ADAPYAdaptimmune Therapeutics PLC | SPONDS ADR | 1,377,294 | $2.34M | 3.3% | 00.0% | Unchanged | History |